Applications of the international scoring system for Disseminated Intravascular Coagulopathy (DIC) and its interaction with Sequential Organ Failure Assessment Score (SOFA) in prediction of prognosis and final outcome in ICU  by Rostom, Ahmed et al.
The Egyptian Journal of Critical Care Medicine (2013) 1, 33–41The Egyptian College of Critical Care Physicians
The Egyptian Journal of Critical Care Medicine
http://ees.elsevier.com/ejccm
www.sciencedirect.comORIGINAL ARTICLEApplications of the international scoring system
for Disseminated Intravascular Coagulopathy (DIC)
and its interaction with Sequential Organ Failure
Assessment Score (SOFA) in prediction of prognosis
and ﬁnal outcome in ICUAhmed Rostom *, Mahmoud Khaled, Mohammed Aﬁfy, Ahmed EL-SherifCritical Care Department, Cairo University, EgyptReceived 20 October 2012; revised 7 November 2012; accepted 15 November 2012
Available online 21 December 2012*
E-
Pe
C
20
OpKEYWORDS
Critically ill patients;
Quantitative D-dimer level;
DIC;
Sepsis;
MODS;
APACHE II score P25;
SOFA score;
DIC score;
Clinical outcome and
mortalityCorresponding author.
mail address: a7madrostom@
er review under responsibili
are Physicians.
Production an
90-7303
en access under CC BY-NC-ND lic
© 2012 The Egyptianhotmail
ty of The
d hostin
httpense.
 College oAbstract Introduction: Disseminated Intravascular Coagulopathy (DIC) is a consumptive syn-
drome that is characterized by simultaneous widespread microvascular thrombosis and profuse
bleeding from various sites. It is described as the combination of thrombocytopenia, decreased
coagulation factors V and X causing prolonged prothrombin time, together with decreased ﬁbrin-
ogen and increased D-dimer levels.
Objectives: (1) To investigate the relation between DIC and increased mortality, (2) to explain
the impact of the changes that occur in ISTH score for DIC in critically ill patients, (3) to determine
the prognostic role of interacting DIC and SOFA scores in critically ill patients and their predictive
capability when combined together than either score alone.
Design: A prospective, comparative, cohort, non-controlled, single center study from July 2011
to January 2012.
Setting: Intensive care unit at Critical Care Department in Kasr-Alainy Hospital of Cairo Uni-
versity.
Patients: Fifty critically ill patients with APACHE II score P25, not including those with dis-
seminated malignancies, chronic liver failure, renal failure or chronic haematological disorders.
Measurements: For all included patients with APACHE II score P25 on admission, DIC and
SOFA scores were calculated at baseline (on admission) and subsequently thereafter every 48 h until.com (A. Rostom).
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Table 1 ISTH scoring system for
Risk assessment
Laboratory tests
Scoring
Interpretation
34 A. Rostom et al.ICU discharge or death or up to a total of 28 days. Clinical outcome (duration of stay in the ICU,
need for mechanical ventilation, need for inotropic/vasopressor support, need for haemodialysis,
and ﬁnal outcome of survival/mortality rates) were recorded.
Results: Through follow up of DIC score trend in both groups (survivors and non-survivors);
increasing value was associated with poor prognosis (96.8% of non-survivors had DIC score value
on admission lower than that before death), while decreasing or constant value was associated with
better prognosis (94.4% of non-survivors had DIC score value on admission higher than or equal to
that before discharge). There was a signiﬁcant correlation between combined DIC and SOFA scores
together with mortality and ﬁnal outcome in ICU (P value was 0.002 at day 4 and 0.012 on dis-
charge or at death).
Conclusion: A signiﬁcant correlation exists between SOFA and DIC scores together in critically
ill patients with APACHE II scoreP25 as regards MODS and mortality. The combination of DIC
and SOFA scores highly improves the prognostic performance of either score alone. It’s recom-
mended to combine these scores together for better mortality prediction.
 2012 The Egyptian College of Critical Care Physicians. Production and hosting by Elsevier B.V.
Open access under CC BY-NC-ND license.Introduction
Disseminated Intravascular Coagulopathy (DIC) is a complex
systemic thrombohemorrhagic disorder involving the genera-
tion of intravascular ﬁbrin and the consumption of procoagu-
lants and platelets. The resultant clinical condition is
characterized by intravascular coagulation and hemorrhage.
The use of the letters ‘‘DIC’’ as an acronym for ‘‘death is com-
ing’’ serves to remind us that much progress remains to be
made in the management of this not uncommon condition [1].
It is an acquired syndrome characterized by intravascular
activation of coagulation with loss of localization arising from
different causes. It can originate from and cause damage to the
microvasculature, which if sufﬁciently severe, can produce or-
gan dysfunction [2].
DIC is not an illness on its own but rather a complication
or an effect of progression of other illnesses and is estimated
to be present in up to 1% of hospitalized patients. DIC is al-
ways secondary to an underlying disorder. Morbidity and
mortality depend on both the underlying disease and the sever-
ity of coagulopathy [3].
DIC is caused by widespread and ongoing activation of
coagulation, leading to vascular or microvascular ﬁbrin depo-
sition, thereby compromising an adequate blood supply to var-
ious organs [4]. There are a number of different triggers that
can cause a hemostatic imbalance, giving rise to a hypercoag-
ulable state. Inﬂammatory cytokines are the most important
mediators responsible for this imbalance. It is clear that there
is cross-communication between coagulation and inﬂamma-DIC [2].
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of the clotting cascade, and the resultant coagulation stimu-
lates more vigorous inﬂammatory activity [5].
The four different mechanisms that are primarily responsible
for the hematologic derangements seen inDIC include increased
thrombin generation, suppression of anticoagulant pathways,
impaired ﬁbrinolysis and inﬂammatory activation [6].
The pathogenesis of DIC starts at the level of the endothe-
lium of the capillary bed where the main interaction between
inﬂammation and coagulation takes place. Endothelial cell
damage results in the release of tissue factor into the circula-
tion, and that initiates the activation of the clotting cascade
[7]. The inﬂammatory Cytokines (including; tumor necrosis
factor a [TNF-a] & interleukin 1 [IL-1]) produced in sepsis
and other generalized inﬂammatory states produce a state of
intense inﬂammatory activity. Exposure to tissue factor in
the circulation occurs via endothelial disruption, tissue dam-
age, or inﬂammatory or tumor cell expression of procoagulant
molecules. Tissue factor activates coagulation by the extrinsic
pathway involving factor VIIa [8]. Evidence suggests that the
intrinsic pathway is also activated in DIC, while contributing
more to hemodynamic instability and hypotension than to
activation of clotting [9].
Extensive bleeding is evident in the form of epistaxis,
gingival bleeding, mucosal bleeding, haemoptysis, bruising,
ecchymosis purpura & petechiae [10]. Manifestations of macro-
vascular thrombosis occur, such as deep venous thrombosis
(DVT). Manifestations of microvascular thrombosis present
as renal failure [11]. Pulmonary involvement is common duetient have an underlying disorder compatible with DIC (e.g., sepsis,
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Applications of the international scoring system for Disseminated Intravascular Coagulopathy (DIC) 35to ARDS [12]. Neurological changes are also possible [13].
Jaundice can be seen because of comorbid liver disease as well
as rapid hemolytic bilirubin production [14]. Skin manifesta-
tions are not uncommon as purpura fulminans, localised infarc-
tion and gangrene [15]. Manifestations of complications may be
present as shock and MODS [16].
Diagnosis of DIC requires a clinical suspicion, predicated
by the presence of an appropriate underlying disease and
abnormal laboratory studies [17]. The diagnosis is made based
on the clinical picture in combination with laboratory studies
Patients with DIC can present with a wide range of abnormal-
ities in their laboratory values. Typically, prolonged coagula-
tion times, thrombocytopenia, high levels of ﬁbrin
breakdown products as elevated D-dimer and ﬁbrin degrada-
tion products (FDPs), reduced ﬁbrinogen and microangio-
pathic pathology (schistocytes) on peripheral blood smears
are suggestive ﬁndings [18]. The International Society on
Thrombosis and Haemostasis (ISTH) developed a simple scor-
ing system for the diagnosis of overt DIC as shown in Table 1.
The diagnostic imaging is based on the areas suggestive of
thrombosis and hemorrhage. Other tests are directed towards
the underlying cause of DIC.
Patients and methods
It is a prospective study including ﬁfty critically ill patients who
were admitted to the Critical Care department at Cairo Uni-
versity from July 2011 to January 2012.
Inclusion criteria:
 Age group (P15 and 680 years).
 Informed consent given by the patient or ﬁrst degree
relative.Table 2 Acute physiology points of APACHE II score.
Physiologic variables High abnormal range
+4 +3 +2 +1
Temperature (rectal) P41 39–40.9 38.5–38
Mean arterial pressure P160 130–159 110–129
Heart rate P180 140–179 110–139
Respiratory rate P50 35–49 25–34
Oxygenation: (mmHg) P500 350–499 200–349
A-aDO2 or PaO2
a. FiO2 P0.5 record
A-aDO2
b. FiO2 60.5 record
only PaO2
Arterial pH P7.7 7.6–7.69 7.5–7.5
Serum sodium P180 160–179 155–159 150–15
Serum potassium P7 6–6.9 5.5–5.9
Serum creatinine P3.5 2–3.4 1.5–1.9
Hematocrite P60 50–59.9 46–49.9
White cell count
(in 1000 s/cm)
P40 20–39.9 15–19.9
Serum HCO3
(if PH is not available)
P52 41–51.9 32–40.9
Glasgow Coma Scale [19] =
15 – actual GCS
A total APS = sum of 12
variable points Critically ill patients with high APACHE II score P25 on
admission or within 24 h of ICU admission (predicted mor-
tality P50%).
Exclusion criteria:
 Extremes of age (<15 and >80 years).
 Disseminated malignancies (Liver metastasis).
 Chronic liver cell failure classiﬁed as Child-Pugh class C.
 Chronic renal failure on regular dialysis.
 Chronic haematological disorders (e.g. leukemia, lym-
phoma, and purpura).
 Patients known to have coagulation defects or receiving
anticoagulation therapy.
 Concomitant treatment with carcinostatics or irradiation.
 Post-cardiopulmonary resuscitation status.
 APACH II score on admission or within 24 h of admission
<25.
 Delay more than 24 h after meeting inclusion criteria.
 Patients went out from ICU against medical advice.
 Those whose investigations could not be done or lost.
 Unknown outcome or loss of patient follow up due to
transfer to other hospitals.
 Missing values of any included patient.
 Refusal of the patient or relatives to sign consent form.
APACHE II score was evaluated in the ﬁrst 24 h of admis-
sion and patients with score P25 who didn’t meet any of the
exclusion criteria were include in our study as shown in Tables
2 and 3.
All studied patients were subjected to signed consent, med-
ical ethics committee approval, detailed history taking, careful
physical examination: including; conscious level: using GlasgowLow abnormal range
0 +1 +2 +3 +4
.9 36–38.4 34–35.9 32–33.9 30–31.9 629.9
70–109 50–69 649
70–109 6–9 40–54 639
12–24 10–11 65
<200
PaO2
>70
PaO2
61–70
PaO2 55–60 PaO2 <55
9 7.3–7.49 7.25–7.32 7.15–7.24 <7.15
4 130–149 120–129 111–119 6110
3.5–5.4 3–3.4 2.5–2.9 <2.5
0.6–1.4 <0.6
30–45.9 20–29.9 <20
3–14.9 1–2.9 <1
22–31.9 18–21.9 15–17.9 <15
Table 3 Age points of APACHE II score.
Age (in years) Points
644 0
45–54 2
55–64 3
65–74 5
P75 6
Table 5 Percentage of age groups for studied
patients.
Age groups (years) Percentage of patients
11–20 2
21–30 0
31–40 2
41–50 10
51–60 22
61–70 28
71–80 36
36 A. Rostom et al.Coma score (GCS), hemodynamics and systemic examination.
Routine laboratory investigations were done together with spe-
cial laboratory investigations (Quantitative Fibrinogen and D-
dimer assays) on day of admission and repeated every 48 h till
discharge.
Length of ICU stay, the need of mechanical ventilation,
need of vasopressor or inotropic support, need of renal
replacement therapy (haemodialysis) and ﬁnal outcome were
evaluated.
DIC and SOFA scores were evaluated on day of admission
and serially every 48 h until discharge as shown in Tables 1 and
4. All patients were followed up clinically and laboratory for a
total of 28 days. Patients were classiﬁed as survivors and non-
survivors and 28-days mortality were studied.
Statistical methods
All obtained data was analyzed statistically by SPSS (Statisti-
cal Package for Social Science) program. Statistical signiﬁ-
cance was analyzed using analysis of variance (ANOVA). All
values was expressed as ranges and means ± SD (Standard
Deviation) for numerical data or numbers and percentages
for categorical data.
Prevalence rate was determined from the number of identi-
ﬁed cases at the time of the study divided by all patients exam-
ined. P value 60.05 was considered statistically signiﬁcant. Chi
square was used as a test of signiﬁcance for the qualitative
data. The relationship between the studied parameters was as-
sayed by Pearson’s correlation coefﬁcient. The cut-off points
will be used as <0.3 for weak correlation, 0.3–0.7 for moder-
ate correlation, and >0.7 for strong correlation.
Chronic health points
If there was severe organ insufﬁciency or immuno-
compromization:Table 4 SOFA score.
SOFA score components 1 2
Respiration: Pa02/FiO2 (mmHg) 300–399 200–299
Coagulation: platelets (·103/mm3) 150–100 50–100
Liver: bilirubin (mg/dl) 1.2–1.9 2.0–5.9
Cardiovascular: hypotension MAP <70
mmHg
Dopamine
65 ug/kg/min
or dobutamin
(any dose)
Cental nervous system: Glasgow
Coma Scale [19]
13–14 10–12
Renal: creatinine (mg/dl) or
urine output
1.2–1.9 2.0–3.4a. For nonoperative or emergency postoperative patients:
ﬁve points.
b. For elective postoperative patients: two points.
APACHE II score equals the summation of APS points,
Age points and chronic health points.
Results
Descriptive data
(1) Demographic analysisA total number of 50 patients
were involved in our study. They included 22 males
(44%) and 28 females (56%) with a mean age of
63.8 ± 12.7 years. Average length of ICU stay was
12 ± 8.9 days.
(2) Age groupsAge groups contributed variably to the
whole patient groups in our study as shown in Table 5.
(3) Gender distributionIn the current study, there was a dis-
crepancy between males and females for cause of admis-
sion. Post-operative ICU care was the commonest cause
for admission in females (32.1%), while major trauma
represent the commonest cause for admission in males
(36.3%) as shown in Table 6.
(4) Outcome of study populationThe clinical outcome of
studied patients was evaluated at day 28 as shown in
Table 7.
Through comparison between patients who improved or sur-
vived and those who died within 28 days of ICU admission, we
found that there was a signiﬁcant variance between both3 4
100–199 <100
20–50 <20
6.0–11.9 >12.0
e
Dopamine >5 ug/k/min
or Epinephrine
<0.1 ug/kg/min
or Norepinephrine
60.1 ug/kg/min
Dopamine >15 ug/kg/min
or Epinephrine
<0.1 ug/kg/min or
Norepinephrine
>0.1 ug/kg/min
6–9 <6
3.5–4.9 or <500 ml/day >5.0 or <200 ml/day
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lue 0.01, <0.001 and <0.001, respectively). While patients
who died showed a signiﬁcant increase in DIC score, those
who improved showed a signiﬁcant decrease in DIC score as
shown in Table 8.DIC 
Figure 1 DIC score at day
DIC score on
Figure 2 DIC score on discha
Table 7 Final outcome of studied patients.
Outcome Frequency Percent
Survivors 18 36
Non-survivors 32 64
Table 6 Cause of admission for males versus females.
Cause of admission Percentage from
total admitted males
Percentage from
total admitted females
Trauma 36.3 7.1
Post-operative care 4.5 32.1
Respiratory failure 18.1 21.4
Sepsis 27.2 14.2
Septic shock 13.6 25
Table 8 DIC score of studied patients at day 2, day 4 and on
discharge.
Outcome DIC score
at day 2
DIC score
at day 4
DIC score
on discharge
Survivors
Mean 2.83 2.67 2.33
Std. Deviation 0.99 0.91 1.09
Non-survivors
Mean 3.59 3.91 4.34
Std. Deviation 0.95 1.17 1.00
P value 0.01 <0.001 <0.001Correlations with patients’ outcome
Fig. 1 shows a statistically signiﬁcant correlation between DIC
scores at day 4 and patients’ outcome (P value <0.001).
Similarly, there was a statistically signiﬁcant correlation be-
tween DIC scores on discharge or at death and patients’ out-
come (P value <0.001) as shown in Fig. 2.score at day 4
4 in relation to outcome.
 discharge or at death
rge in relation to outcome.
Figure 3 ROC curve for DIC score at day 4 as a determinant of
outcome.
Figure 4 ROC curve for DIC score on discharge as a determi-
nant of outcome.
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Figure 5 DIC score trend in survivors and non-survivors.
38 A. Rostom et al.Receiver operating characteristic (ROC) curves analyses
When ROC curve was used to determine DIC score at day 4 as
a determinant of outcome, the area under the curve was 80.9%Figure 6 Correlation between interacting DIC
Figure 7 Correlation between interacting DIC a
Table 9 Cause of admission in relation to patients’ mortality.
Percentage of patients
with DIC score P5
Percentage of
non-survivors
Cause of admission
70 100 Shock
42.8 70 Trauma
42.8 70 Post-operative care
16.6 60 Respiratory failure
50 20 Sepsisand the best cut-off value was 2.5 with a sensitivity of 96.9%
and a speciﬁcity of 38.9% (Fig. 3).
When ROC curve was used to determine DIC score upon
discharge as a determinant of outcome, the area under the
curve was 90.6% and the best cut-off value was 2.5 with a sen-
sitivity of 96.9% and a speciﬁcity of 66.7% (Fig. 4).
Mortality data
In the current study, 32 out of 50 critically ill patients died
while 18 survived with an average mortality rate of 64%.
About 71.4% of our studied patient with DIC score P5 on
day 0 (i.e. diagnosed as overt DIC since admission) died.
About 46.87% of our included critically ill patients who died
in our study have DIC scoreP5 either on admission or during
follow up.and SOFA scores at day 4 with mortality.
nd SOFA scores on discharge with mortality.
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patients (those who improved and those who died), our study
showed that: about 96.8% of our study patients who died have
DIC score value on admission lower than that before death. In
contrast, about 94.4% of our study patients who survived have
DIC score value on admission higher than or equal to that be-
fore discharge as in Fig. 5.
The relation between the cause of admission and patients’
mortality in non-survivors was shown in Table 9.
Interacting SOFA and DIC scores on mortality
In the present work, we explored interactions of combined
SOFA score and DIC score at day 4 and on discharge or death
upon patients’ outcome (improved or died).
 Combined SOFA and DIC scores at day 4:Odds of outcome
occurrence (i.e. death) increases 1.17 times with each unit
increase in SOFA & DIC scores, interacting together (P
value 0.002). As shown in Fig. 6, survivors had lower SOFA
& DIC scores, while non-survivors had higher SOFA &
DIC scores.
 Combined SOFA and DIC scores on discharge:Odds of out-
come occurrence (i.e. death) increases 1.5 times with each
unit increase in SOFA & DIC scores, interacting together
(P value 0.012). As shown in Fig. 7, survivors had lower
SOFA & DIC scores, while non-survivors had higher SOFA
& DIC scores.
Discussion
Early assessment of critically ill patients and accurate predic-
tion of prognosis in the intensive care unit are important to al-
low appropriate treatment decisions by patients, relatives, and
medical attendants [20]. In general, the earlier an accurate
diagnosis is made and appropriate treatment started, the great-
er the chance of survival, fewer complications, better quality of
life, and lower health care costs [21,22]. Therefore, the need to
identify scores that aid clinicians in diagnosis, prognosis, and
disease monitoring is driving the clinical scientiﬁc research
[23,24]. The most commonly available tools for prediction of
prognosis in ICU are APACHE II score (Acute Physiology
and Chronic Health Evaluation) and SOFA score (Sequential
Organ Failure Assessment) which predict morbidity and mor-
tality of critically ill patients [25,26].
These scoring systems are based on several physiological
indices and chemical variables. Over the years, several problems,
pitfalls, and limitations of these scoring systems have been iden-
tiﬁed. Furthermore, they are very cumbersome and time con-
suming to apply, as they are based on several biochemical
measurements and several physiological indices [20]. Although
numerous scoring systems have been evaluated to predict mor-
bidity and mortality of critically ill patients in the intensive care
setting, yet none of them has proven entirely useful.
Interest has been developed in the use of DIC (Dissemi-
nated Intravascular Coagulopathy) score as a prognostic mar-
ker for critically ill patients in ICU [27]. Our study used a
simple scoring system that was developed by the International
Society of Thrombosis and Haemostasis (ISTH) as a diagnos-
tic approach with good sensitivity and high speciﬁcity depend-
ing on a set of criteria for the diagnosis of DIC including thepresence of an underlying disorder, platelet count, prothrom-
bin time, quantitative D-dimer and ﬁbrinogen levels. A score
of ﬁve points or greater indicates overt DIC, while a score of
less than ﬁve points does not rule out DIC but may indicate
non-overt DIC [2].
In the current study, DIC score was higher on admission
in patients with APACHE II score P25 who died when
compared to those who survived or improved with no statis-
tical signiﬁcance (P value 0.967) this might be due to limited
number of studied patients. However, there was a statisti-
cally signiﬁcant higher DIC score in patients with APACHE
II score P25 who died when compared to those who sur-
vived or improved at day 2, day 4 and upon discharge or
at death (P value 0.01, <0.001 and <0.001, respectively).
Our study also reported that there was a signiﬁcant correla-
tion between DIC score at day 4 and on discharge or at
death with the outcome of patients with APACHE II score
P25 (P value <0.001).
In agreement with our results, Battah et al. conducted a
study in 2010 showing that DIC score in the ﬁrst 48 h was
an accurate predictor of clinical course and outcome [28].
However, the latter study included only patients with sepsis
and used SOFA and DIC scores only during the ﬁrst 48 h of
admission. Furthermore, Battah et al. used only two of the
coagulation variables needed to calculate DIC score (platelets
count and prothrombin time). In contrast, our study included
various etiologies for ICU admission, and used SOFA and
DIC scores at day 0, day 2 and day 4 during ICU stay and
upon discharge or at death, in addition to the use of all of
the four essential parameters needed to calculate ISTH score
for DIC (including; platelets’ count, prothrombin time, quan-
titative serum ﬁbrinogen and D-dimer levels).
In our study, the changes that occured in DIC score from
admission to 48 h later represented an accurate predictor of
clinical course and may have reﬂected improvement or worsen-
ing of the underlying disease. We chose to award points even
when the absolute values of PT and/or platelet count were
within normal range. This may highlight the value of change
over time rather than single admission score.
These results agree with the results of the study of Dhainaut
et al. who noted in 2005 that worsening coagulopathy corre-
lated with worsening outcome in patients with severe sepsis
[29]. However, Dhainaut et al. didn’t use the ISTH scoring sys-
tem in his study to diagnose patients with DIC.
Also the present study showed that there was a statistically
signiﬁcant correlation between combined DIC and SOFA
score in both groups of patients and clinical outcome at day
4 and on discharge or at death. Since the studied scores used
to prognosticate patients’ outcome have shown variable data
in various studies and regarding the previously discussed con-
ﬂicting data for these scores, we recommend combining
APACHE II, SOFA and DIC scores together in order to im-
prove the prognostic capability of these scores.
In our work, we have combined SOFA score together with
DIC score to improve the predictive power of the scoring sys-
tems used in critically ill patients with APACHE II scoreP25.
Our results were supported by a retrospective study conducted
in 2006 by Kazuhiro et al. showing that combination of
APACHE II score and DIC score predicted mortality better
than the APACHE II score alone [30].
In contrast, we disagree with the study of Hiromoto et al.
that was performed in 2012 on patients with severe trauma
40 A. Rostom et al.showing that DIC and SOFA scores at day 0 were not pre-
dictive of the progression of DIC in traumatic patients [31].
This might be explained by the use of DIC and SOFA
scores only on day 0 in their study, while our study com-
pared DIC and SOFA score on day 0, 2, 4 and upon dis-
charge or at death.
Our research demonstrated that DIC score could be used as
a potentially useful marker that is easy to perform and inter-
pret for the evaluation of critically ill patients when admitted
to the ICU and for early prognosis and prediction of their ad-
verse outcomes and rapid risk stratiﬁcation that might allow
clinicians to make more rational therapeutic decisions and to
ensure that the hospital resources are used efﬁciently and
appropriately which is of particular signiﬁcance in the inten-
sive care environment.
Conclusion
There is a strong correlation between Disseminated Intravas-
cular Coagulopathy (DIC) in critically ill patients with poor ﬁ-
nal outcome and increased mortality in ICU.
Increasing value of DIC score during follow up of critically
ill patients is associated with poor prognosis even if it is incom-
patible with the diagnosis of overt DIC (i.e. DIC < 5), while
decreasing or constant value of DIC score is associated with
better prognosis.
The combination of the different scoring models strongly
supports and highly improves the prognostic performance of
either model alone.
Recommendation
We recommend using the promising ISTH scoring system for
DIC to predict mortality and prognosis in critically ill patients
with APACHE II scoreP25. Serum quantitative D-dimer and
ﬁbrinogen levels are required to calculate DIC score.
Not only using single measurement of DIC score, but also
following up the trend of DIC score of critically ill patients
with APACHE II score P25 every 48 h during ICU stay,
whether it is declining or constant or increasing is essential
in order to help in determination of the clinical course of the
underlying disease and to detect the response to applied
treatment.
We also do recommend the combined use of SOFA score
together with DIC score for better prediction of mortality of
critically ill patients in intensive care unit.
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